Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternative treatment protocols in giardiasis: a pilot study

B U Bulut1, S B Gülnar, D Aysev

  • 1Division of Social Pediatrics, Ankara University School of Medicine, Turkey.

Scandinavian Journal of Infectious Diseases
|January 1, 1996
PubMed
Summary

Ornidazole offers a highly effective, single-dose treatment for giardiasis in children, showing 100% efficacy. This new protocol is a promising, less toxic alternative to conventional giardiasis treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.

Rheumatology international·2006
Same author

Detection of virulence factors of Escherichia coli from children by multiplex polymerase chain reaction.

International journal of clinical practice·2006
Same author

Genotype distribution of Candida albicans isolates by 25S intron analysis with regard to invasiveness.

Mycoses·2004
Same author

Antistreptococcal response is exaggerated in children with familial Mediterranean fever.

Clinical rheumatology·2002
Same author

Attitudes and practices of breastfeeding mothers regarding fasting in Ramadan.

Child: care, health and development·2001
Same author

Fungi balls and treatment in infancy.

Pediatrics international : official journal of the Japan Pediatric Society·2001

Area of Science:

  • Pediatric infectious diseases
  • Parasitology
  • Clinical pharmacology

Background:

  • Giardiasis remains a significant public health concern, particularly in pediatric populations.
  • Current treatment protocols for giardiasis often involve multiple doses and can have notable side effects or higher costs.
  • There is a need for novel, more accessible, and safer treatment options for giardiasis.

Purpose of the Study:

  • To evaluate the efficacy and safety of four distinct treatment protocols for childhood giardiasis.
  • To identify a treatment regimen that is less toxic, more cost-effective, and simpler to administer compared to standard therapies.
  • To compare ornidazole, metronidazole, and mebendazole in treating giardiasis.

Main Methods:

  • A randomized controlled trial involving 48 children diagnosed with giardiasis.

Related Experiment Videos

  • Four treatment groups were established: mebendazole (100 mg t.i.d. for 1 day), mebendazole (100 mg t.i.d. for 7 days), metronidazole (15 mg/kg for 7 days), and ornidazole (40 mg/kg single dose).
  • Treatment efficacy was assessed via microscopic stool examination, and side effects were monitored.

    • Main Results:

    • Ornidazole demonstrated 100% efficacy, followed by metronidazole (92.9%), mebendazole (7 days, 58.3%), and mebendazole (1 day, 41.7%).
    • Ornidazole exhibited a favorable safety profile, with only minor side effects (urticaria, vertigo, nausea) reported in 3 children.
    • The single-dose ornidazole protocol proved to be the most effective and well-tolerated treatment.

    Conclusions:

    • Single-dose ornidazole (40 mg/kg) is a highly effective and safe alternative treatment for pediatric giardiasis.
    • Further research is recommended to establish the optimal and safest single-dose regimen for ornidazole.
    • Novel treatment strategies like single-dose ornidazole can improve patient compliance and treatment outcomes for giardiasis.